TipRanks on MSN

MeiraGTx’s Gene Therapy Trial: A Potential Game-Changer for Radiation-Induced Xerostomia

Detailed price information for Meiragtx Holdings Plc (MGTX-Q) from The Globe and Mail including charting and trades.

MeiraGTx’s Gene Therapy Study for Xerostomia: A Promising Update

Detailed price information for Meiragtx Holdings Plc (MGTX-Q) from The Globe and Mail including charting and trades.
The Nassau Guardian

Smart solutions for a common complaint - dry mouth

Dry mouth, also known as xerostomia, is more than just a temporary nuisance. It can affect how you speak, taste, chew, and ...

The hidden causes of your bad breath - and EXACTLY how to beat it. Plus how to tell if it’s a sign of a serious lurking health problem, reveals DR PHILIPPA KAYE

The patient - let's call her Melanie - in my consulting room looked absolutely mortified. 'What seems to be the problem,' I ...
pharmaphorum

MeiraGTx plans to take Parkinson's gene therapy into phase 3

Armed with data from a small phase 1/2 bridging study, MeiraGTx is preparing to take its gene therapy for Parkinson's disease into a pivotal trial. Shares in the Anglo-US biotech rose sharply after ...
ascopubs.org

Transoral Robotic Surgery in the Multidisciplinary Care of Patients With Oropharyngeal Squamous Cell Carcinoma: ASCO Guideline

Botensilimab (Fc-enhanced anti–cytotoxic lymphocyte-association protein-4 antibody) Plus Balstilimab (anti–PD-1 antibody) in Patients With Relapsed/Refractory Metastatic Sarcomas ASCO Guidelines ...